![Page 1: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/1.jpg)
.1
Overview of B&W Medical Isotope Production System
Foundation for Nuclear Studies
September 27, 2011
Steve SchilthelmDeputy Program Manager
![Page 2: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/2.jpg)
.2
The Babcock & Wilcox CompanyGovernment Operations Power Generation Systems
High-Consequence Operations & Services
Advanced Engineering and Manufacturing
Manufactures and services coal, biomass, CNG, concentrated solar power plant equipment, & Nox, Sox, mercury scrubbers
Manufactures nuclear components for U.S. Department of Energy
Manufactures commercial nuclear components and provides services to commercial nuclear market
Manages and operates high-consequence facilities, provides technical services and support to government agencies and private customers
B&W NuclearOperations Group, Inc.
B&W Power Generation Group, Inc.
B&W NuclearEnergy , Inc.
B&W TechnicalServices Group, Inc.
![Page 3: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/3.jpg)
.3
Covidien Reach Extends Globally and Locally
Diverse healthcare products used in all clinical settings
20,000+ U.S. employees, 41,000+ worldwide
Products manufactured in17 states
Covidien Tc 99m-based products sold in all 50 states
Nuclear Medicine:
One of two U.S. suppliers oftechnetium 99m (Tc 99m)
Image used by permission of Covidien
![Page 4: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/4.jpg)
.4
B&W MIPS – 99Mo Production Using Aqueous Homogeneous Reactor
Market studies in Late 1990s Patented in 1997 (Dr. Russell M. Ball)
2007 MIPS project re-initiated 2009 Agreement with Covidien 2009 Cooperative Agreement with NNSA
Non-proliferation (LEU)
Domestic supply
AHR using LEU offers safety, safeguards, simplicity and waste advantages
![Page 5: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/5.jpg)
.5
Over 30 AHRs Built and Operated
AHRs are not New Technology
CLEVELAND, OHCLEVELAND, OH
SHEBA Reactor, LANL
![Page 6: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/6.jpg)
.6
AHR - America’s First University Reactor
N.C. State’s – R1 (1953-73)
![Page 7: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/7.jpg)
.7
Dissolved Target Waste with 235U
Traditional Technology235U Target Fabrication
Target Irradiation: Several days Reactor: 10,000 -100,000 kilowatts
Transport
99mTc Generator Facility
Tran
spor
t
Transport
99Mo Processing Facility
99mTc User Medical Facilities
Transpo
rt
![Page 8: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/8.jpg)
.8
B&W MIPS Technology
Transp
o
rt
99mTc User Medical Facilities
99mTc Generator Facility
AHR Reactor 240 kilowatts- 5 days
Reactor fuel/target solution returned for subsequent irradiation
Initial Fuel Solution Preparation
MIPS Facility
99Mo Processing Cells
Tran
spo
rt
![Page 9: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/9.jpg)
.9
Completing R&D Phase of Project
National Laboratories Argonne
Los Alamos
Armed Forces Radiobiology Research Institute, MD
Purdue University
B&W Labs, VA
INVAP, Argentina
![Page 10: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/10.jpg)
.10
MIPS Project Progress
Conceptual design complete NRC licensing and waste policy decisions
complete Environmental analysis prepared Completing R&D activities Following legislation (HR 3276, S 99) Entering detailed design and licensing phase of
the project
![Page 11: 1 Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager](https://reader035.vdocuments.us/reader035/viewer/2022062713/56649cd95503460f949a31ef/html5/thumbnails/11.jpg)
.11
B&W MIPS Summary
Mo-99 production using LEU AHR results in:
Increased efficiencyReduced waste No proliferation concernsSafe operationStable domestic supply